Orphazyme files for delisting in US
![Photo: Orphazyme / PR](https://photos.watchmedier.dk/watchmedier/resize:fill:3840:0:0/plain/https://photos.watchmedier.dk/Images/article13848190.ece/ALTERNATES/schema-16_9/doc7k89v4t2jgy1hccx053e.jpg)
Embattled biotech company Orphazyme has filed for a voluntary delisting of its American Depositary Shares (ADS) from Nasdaq Global, a company press release reports on Monday evening.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
Get full access for you and your coworkers
Start a free company trial todayRelated articles
Orphazyme seeks court protection during restructuring
For subscribers